X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (1492) 1492
animals (1431) 1431
male (1083) 1083
rats (1083) 1083
pharmacology & pharmacy (1077) 1077
dopamine (753) 753
d-1 (725) 725
index medicus (513) 513
psychiatry (457) 457
benzazepines - pharmacology (422) 422
rats, sprague-dawley (377) 377
humans (376) 376
rat (337) 337
mice (331) 331
brain (330) 330
female (315) 315
receptors (311) 311
nucleus-accumbens (309) 309
striatum (300) 300
d-1 receptor (289) 289
dose-response relationship, drug (286) 286
d-1 receptors (283) 283
dopamine d-1 (281) 281
dopamine antagonists - pharmacology (276) 276
receptors, dopamine d1 - metabolism (271) 271
schizophrenia (270) 270
dopamine d-1 receptor (268) 268
prefrontal cortex (264) 264
motor activity - drug effects (261) 261
dopamine agonists - pharmacology (260) 260
cocaine (251) 251
neurons (251) 251
receptor (236) 236
behavioral sciences (231) 231
biochemistry & molecular biology (230) 230
expression (217) 217
behavior, animal - drug effects (216) 216
basal ganglia (212) 212
sch 23390 (211) 211
receptors, dopamine - drug effects (203) 203
parkinsons-disease (199) 199
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine - pharmacology (192) 192
dopamine receptors (192) 192
rats, wistar (191) 191
agonists (189) 189
rat-brain (188) 188
sch-23390 (188) 188
dopamine - metabolism (187) 187
amphetamine (186) 186
stimulation (185) 185
clinical neurology (184) 184
nucleus accumbens (180) 180
dopamine d-1 receptors (171) 171
binding (168) 168
quinpirole (168) 168
rats, inbred strains (160) 160
receptors, dopamine d1 - antagonists & inhibitors (158) 158
activation (154) 154
corpus striatum - metabolism (154) 154
behavior (150) 150
article (148) 148
dopamine d (147) 147
receptors, dopamine d1 - agonists (146) 146
apomorphine (143) 143
antagonists (141) 141
receptors, dopamine - metabolism (138) 138
receptors, dopamine d2 - metabolism (138) 138
corpus striatum - drug effects (137) 137
dopamine - physiology (135) 135
parkinson's disease (134) 134
ventral tegmental area (134) 134
receptors, dopamine d1 - drug effects (133) 133
haloperidol (131) 131
working-memory (130) 130
dopamine agents - pharmacology (128) 128
in-vivo (127) 127
receptors, dopamine d1 - physiology (125) 125
agonist (124) 124
reward (122) 122
time factors (121) 121
release (118) 118
brain - metabolism (116) 116
locomotor-activity (115) 115
receptors, dopamine d1 (115) 115
dopamine receptor (110) 110
messenger-rna (110) 110
neurons - drug effects (110) 110
modulation (109) 109
apomorphine - pharmacology (108) 108
dopamine d2 receptor antagonists (106) 106
haloperidol - pharmacology (106) 106
antipsychotic agents - pharmacology (105) 105
antagonist (104) 104
phenols (104) 104
stereotyped behavior - drug effects (104) 104
cocaine - pharmacology (98) 98
medial prefrontal cortex (98) 98
gene-expression (97) 97
behavioral sensitization (96) 96
receptors, dopamine d2 - drug effects (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2730) 2730
Spanish (7) 7
Russian (5) 5
French (4) 4
Japanese (4) 4
Danish (2) 2
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 02/2009, Volume 34, Issue 3, pp. 681 - 697
Psychopharmacological studies have implicated the mesolimbic dopamine (DA) system in the mediation of cost/benefit evaluations about delay or effort-related... 
Discounting | Gambling | Amphetamine | Parkinson's disease | receptors | D-1 RECEPTOR | PSYCHIATRY | discounting | amphetamine | gambling | NEUROCHEMICAL PROFILE | NORMAL VOLUNTEERS | NEUROSCIENCES | VENTROMEDIAL PREFRONTAL CORTEX | D-2 receptors | IMPULSIVE BEHAVIOR | D-3 receptors | PHARMACOLOGY & PHARMACY | RECEPTOR GENE | D-AMPHETAMINE | PROBABILISTIC REINFORCEMENT | WORKING-MEMORY | PARKINSONS-DISEASE | Receptors, Dopamine D4 - agonists | Rats, Long-Evans | Decision Making - drug effects | Risk | Receptors, Dopamine D4 - antagonists & inhibitors | Pyrrolidines - pharmacology | Conditioning, Operant - drug effects | Receptors, Dopamine D1 - agonists | Behavior, Animal - drug effects | Benzamides - pharmacology | Benzopyrans - pharmacology | Receptors, Dopamine D3 - antagonists & inhibitors | Oxazines - pharmacology | Receptors, Dopamine D1 - antagonists & inhibitors | Dopamine Agonists - pharmacology | Dextroamphetamine - pharmacology | Receptors, Dopamine D2 - agonists | Rats | Behavior, Animal - physiology | Bromocriptine - pharmacology | Benzazepines - pharmacology | Piperazines - pharmacology | Naphthalenes - pharmacology | Receptors, Dopamine D3 - agonists | Reinforcement Schedule | Pyrroles - pharmacology | Animals | Dopamine Antagonists - pharmacology | Decision Making - physiology | Pyridines - pharmacology | Dopamine D2 Receptor Antagonists | Salicylamides - pharmacology
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 11/2010, Volume 285, Issue 45, pp. 35092 - 35103
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 04/2013, Volume 38, Issue 5, pp. 715 - 728
Journal Article
Molecular Pharmacology, ISSN 0026-895X, 10/2014, Volume 86, Issue 4, pp. 417 - 429
The dopamine D-1 receptor-D-3 receptor (D1R-D3R) heteromer is being considered as a potential therapeutic target for neuropsychiatric disorders. Previous... 
FORMS | INTERFACE | ADENYLYL-CYCLASE | RELEVANCE | TARGETS | D-1 | PHARMACOLOGY & PHARMACY | BRAIN | HETEROMERIZATION
Journal Article
Neuropharmacology, ISSN 0028-3908, 12/2016, Volume 111, pp. 160 - 168
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2016, Volume 81, Issue 1, pp. 67 - 77
Journal Article